These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7908733)
1. Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation. Qian X; Dougall WC; Hellman ME; Greene MI Oncogene; 1994 May; 9(5):1507-14. PubMed ID: 7908733 [TBL] [Abstract][Full Text] [Related]
2. Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses. Starbuck C; Lauffenburger DA Biotechnol Prog; 1992; 8(2):132-43. PubMed ID: 1368006 [TBL] [Abstract][Full Text] [Related]
3. Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy. Dougall WC; Qian X; Greene MI J Cell Biochem; 1993 Sep; 53(1):61-73. PubMed ID: 7901229 [TBL] [Abstract][Full Text] [Related]
4. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation. Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of the early genomic growth factor response in neu oncogene-transformed cells. Sistonen L; Koskinen PJ; Lehväslaiho H; Lehtola L; Bravo R; Alitalo K Oncogene; 1990 Jun; 5(6):815-21. PubMed ID: 1972791 [TBL] [Abstract][Full Text] [Related]
6. Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation. Qian X; LeVea CM; Freeman JK; Dougall WC; Greene MI Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1500-4. PubMed ID: 7509075 [TBL] [Abstract][Full Text] [Related]
7. Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase. Ge G; Wu J; Wang Y; Lin Q Biochem Biophys Res Commun; 2002 Jan; 290(3):914-20. PubMed ID: 11798160 [TBL] [Abstract][Full Text] [Related]
8. Activation of an EGFR/neu chimeric receptor: early intracellular signals and cell proliferation responses. Pandiella A; Lehvaslaiho H; Magni M; Alitalo K; Meldolesi J Oncogene; 1989 Nov; 4(11):1299-305. PubMed ID: 2573029 [TBL] [Abstract][Full Text] [Related]
9. Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins. Wada T; Myers JN; Kokai Y; Brown VI; Hamuro J; LeVea CM; Greene MI Oncogene; 1990 Apr; 5(4):489-95. PubMed ID: 1970151 [TBL] [Abstract][Full Text] [Related]
10. Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase. Lehväslaiho H; Sistonen L; diRenzo F; Partanen J; Comoglio P; Hölttä E; Alitalo K J Cell Biochem; 1990 Mar; 42(3):123-33. PubMed ID: 1969420 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer. Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460 [TBL] [Abstract][Full Text] [Related]
12. Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors. Haley JD; Hsuan JJ; Waterfield MD Oncogene; 1989 Mar; 4(3):273-83. PubMed ID: 2784850 [TBL] [Abstract][Full Text] [Related]
13. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations. Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020 [TBL] [Abstract][Full Text] [Related]
15. The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired. Sorkin A; Di Fiore PP; Carpenter G Oncogene; 1993 Nov; 8(11):3021-8. PubMed ID: 8105439 [TBL] [Abstract][Full Text] [Related]
16. Similar early gene responses to ligand-activated EGFR and neu tyrosine kinases in NIH3T3 cells. Koskinen P; Lehväslaiho H; MacDonald-Bravo H; Alitalo K; Bravo R Oncogene; 1990 Apr; 5(4):615-8. PubMed ID: 1970155 [TBL] [Abstract][Full Text] [Related]
17. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA. Li J; Ma C; Huang Y; Luo J; Huang C Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890 [TBL] [Abstract][Full Text] [Related]
18. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982 [TBL] [Abstract][Full Text] [Related]
19. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Huang Y; Li X; Jiang J; Frank SJ Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991 [TBL] [Abstract][Full Text] [Related]
20. Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor. Burgaud JL; Baserga R Exp Cell Res; 1996 Mar; 223(2):412-9. PubMed ID: 8601418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]